NIVF plunges on Nasdaq alert for 1-for-3 reverse stock split effective July 6
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $5.43M | $5.14M | $5.94M | $4.12M |
| Cost of Revenue | $3.61M | $3.45M | $4.41M | $3.09M |
| Gross Profit | $1.83M | $1.68M | $1.54M | $1.02M |
| Gross Margin | 33.63% | 32.75% | 25.87% | 24.89% |
| Operating Expenses | $2.99M | $1.64M | $2.04M | $826.24K |
| Operating Income | $-1.16M | $42.24K | $-504.91K | $198.76K |
| Operating Margin | -21.35% | 0.82% | -8.49% | 4.83% |
| Net Income | $-525.00K | $130.19K | $458.67K | $-533.00 |
| Net Margin | -9.66% | 2.53% | 7.72% | -0.01% |
| EPS (Basic) | $-115.25 | $64.25 | $323.00 | $-0.03 |
| EBITDA | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A |